ZA855409B - New substituted amides,and their preparation and use - Google Patents

New substituted amides,and their preparation and use

Info

Publication number
ZA855409B
ZA855409B ZA855409A ZA855409A ZA855409B ZA 855409 B ZA855409 B ZA 855409B ZA 855409 A ZA855409 A ZA 855409A ZA 855409 A ZA855409 A ZA 855409A ZA 855409 B ZA855409 B ZA 855409B
Authority
ZA
South Africa
Prior art keywords
radical
alkyloxy
alkyl
het
optionally substituted
Prior art date
Application number
ZA855409A
Other languages
English (en)
Inventor
Claude Cotrel
Claude Guyon
Gerard Roussel
Gerard Taurand
Original Assignee
Rhone Poulenc Sante
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rhone Poulenc Sante filed Critical Rhone Poulenc Sante
Publication of ZA855409B publication Critical patent/ZA855409B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/79—Acids; Esters
    • C07D213/80—Acids; Esters in position 3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/02—Antidotes
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/38—Nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurology (AREA)
  • Engineering & Computer Science (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Pain & Pain Management (AREA)
  • Toxicology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Anesthesiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pyridine Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Materials For Medical Uses (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Cephalosporin Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Quinoline Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
ZA855409A 1984-07-19 1985-07-17 New substituted amides,and their preparation and use ZA855409B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8411442A FR2567887B1 (fr) 1984-07-19 1984-07-19 Nouveaux amides substitues, leur preparation et les medicaments qui les contiennent

Publications (1)

Publication Number Publication Date
ZA855409B true ZA855409B (en) 1986-04-30

Family

ID=9306273

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA855409A ZA855409B (en) 1984-07-19 1985-07-17 New substituted amides,and their preparation and use

Country Status (27)

Country Link
US (1) US4642308A (de)
EP (1) EP0172083B1 (de)
JP (1) JPS6163656A (de)
KR (1) KR860001100A (de)
AT (1) ATE33652T1 (de)
AU (1) AU572672B2 (de)
CA (1) CA1224787A (de)
CS (1) CS253730B2 (de)
DD (1) DD240011A5 (de)
DE (1) DE3562250D1 (de)
DK (1) DK327285A (de)
ES (1) ES8604584A1 (de)
FI (1) FI79313C (de)
FR (1) FR2567887B1 (de)
GR (1) GR851774B (de)
HU (1) HU199802B (de)
IL (1) IL75817A (de)
MA (1) MA20487A1 (de)
NO (1) NO161673C (de)
NZ (1) NZ212764A (de)
OA (1) OA08069A (de)
PH (1) PH21301A (de)
PL (1) PL145331B1 (de)
PT (1) PT80840B (de)
SU (1) SU1417797A3 (de)
YU (1) YU118785A (de)
ZA (1) ZA855409B (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4720500A (en) * 1985-07-11 1988-01-19 Rhone-Poulenc Sante N-1,8-naphthyridin-2-yl amides useful as immunostimulants
FR2592882B2 (fr) * 1986-01-16 1988-03-11 Rhone Poulenc Sante Nouveaux amides substitues, leur preparation et les medicaments qui les contiennent
US4753941A (en) * 1986-01-16 1988-06-28 Rhone-Poulenc Sante Amides based on certain 1,8-naphtyridine-2-amines useful as anxiolytics
US5197518A (en) * 1991-06-27 1993-03-30 Double Containment Systems Centering support assembly for double containment pipe systems
GB9711257D0 (en) * 1997-05-30 1997-07-30 Smithkline Beecham Plc Novel compounds
DE60001218D1 (de) * 1999-02-22 2003-02-20 Shire Biochem Inc [1,8]-naphthyridinderivate derivate mit antiviraler wirkung
MXPA06003951A (es) * 2003-10-07 2006-06-27 Renovis Inc Derivados de amida como ligandos del canal de ion y composiciones farmaceuticas y sus metodos de uso.
US7576099B2 (en) 2005-02-28 2009-08-18 Renovis, Inc. Amide derivatives as ion-channel ligands and pharmaceutical compositions and methods of using the same
MX2007009381A (es) * 2005-02-28 2007-09-25 Renovis Inc Derivados de amida como ligandos de canales ionicos y composiciones farmaceuticas y metodos para usar los mismos.
WO2013090725A1 (en) * 2011-12-15 2013-06-20 Philadelphia Health & Education Corporation NOVEL PI3K p110 INHIBITORS AND METHODS OF USE THEREOF
CN105646487B (zh) * 2016-03-15 2017-12-05 红河学院 一类溴代1,8‑萘啶衍生物及其制备方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1006725A (fr) * 1948-08-31 1952-04-28 Cilag Spa Nouveaux dérivés de la naphtyridine et procédé pour leur préparation
GB661515A (en) * 1948-08-31 1951-11-21 Cilag Ltd Process for the production of naphthyridine derivatives
US3389142A (en) * 1966-09-29 1968-06-18 Bristol Myers Co Esters of 2-substituted 1, 2-dihydroquinoline-nu-carboxylic acids and thione acids
US3576809A (en) * 1968-05-06 1971-04-27 Miles Lab 2-substituted derivatives of 6-methoxyquinoline
US3624097A (en) * 1969-07-22 1971-11-30 Warner Lambert Co N-pyridine 5-aminooxazoles
US4466965A (en) * 1982-07-26 1984-08-21 American Hospital Supply Corporation Phthalazine compounds, compositions and use

Also Published As

Publication number Publication date
PH21301A (en) 1987-09-28
PL145331B1 (en) 1988-09-30
SU1417797A3 (ru) 1988-08-15
AU4509085A (en) 1986-01-23
US4642308A (en) 1987-02-10
DE3562250D1 (en) 1988-05-26
NO161673C (no) 1989-09-13
PT80840A (fr) 1985-08-01
JPS6163656A (ja) 1986-04-01
IL75817A (en) 1988-06-30
HU199802B (en) 1990-03-28
OA08069A (fr) 1987-03-31
EP0172083A1 (de) 1986-02-19
CS253730B2 (en) 1987-12-17
CA1224787A (fr) 1987-07-28
HUT40799A (en) 1987-02-27
FR2567887B1 (fr) 1986-12-19
FI852821A0 (fi) 1985-07-18
AU572672B2 (en) 1988-05-12
IL75817A0 (en) 1985-11-29
FI79313B (fi) 1989-08-31
ES545336A0 (es) 1986-02-01
ES8604584A1 (es) 1986-02-01
FI79313C (fi) 1989-12-11
FR2567887A1 (fr) 1986-01-24
DK327285D0 (da) 1985-07-18
NO161673B (no) 1989-06-05
EP0172083B1 (de) 1988-04-20
DD240011A5 (de) 1986-10-15
NO852877L (no) 1986-01-20
KR860001100A (ko) 1986-02-22
ATE33652T1 (de) 1988-05-15
DK327285A (da) 1986-01-20
MA20487A1 (fr) 1986-04-01
FI852821L (fi) 1986-01-20
PL254570A1 (en) 1986-10-21
YU118785A (en) 1988-10-31
PT80840B (pt) 1988-02-17
GR851774B (de) 1985-11-26
NZ212764A (en) 1988-05-30

Similar Documents

Publication Publication Date Title
DE3562250D1 (en) Substituted amides, their preparation and pharmaceutical compositions containing them
EP0478362A3 (en) Fibrinogen receptor antagonists
EP0422456A3 (en) Pyridine derivatives and their use in combating unwanted plant growth
ES8602761A1 (es) Un procedimiento para preparar un derivado de primidona
AU589484B2 (en) New substituted amides, their preparation and pharmaceutical compositions which contain them
FR2660313B1 (fr) Nouveau sulfonyl-phenyl-betha-d-thioxylosides, leur procede de preparation et leur utilisation en therapeutique.
GR3000546T3 (en) Substituted amides, their preparation and pharmaceutical compositions containing them
NZ225771A (en) Heterocyclically-substituted chloroaniline derivatives and pharmaceutical compositions: processes for preparation
JO1697B1 (en) Pyridine derivatives
IL97715A0 (en) Inclusion complexes of 3-morpholino-sydnonimine or its salts or its tautomer isomer,process for the preparation thereof,and pharmaceutical compositions containing the same
HU00224A9 (en) Inclusion complexes of 3-morpholino-sydnonimine or its salts or its tautomer isomer, process for the preparation thereof, and pharmaceutical compositions containing the same